HTG Molecular Diagnostics Announces Pricing of a $10 Million Public Offering
December 21, 2022 13:15 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Dec. 21, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
HTG Announces One-for-Twelve Reverse Stock Split
December 20, 2022 16:30 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Dec. 20, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
HTG Molecular Diagnostics Announces the Next Event in its RNA Profiling in Drug Discovery KOL Webcast Series
December 09, 2022 08:01 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Dec. 09, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
HTG Technology Featured Across Numerous Abstracts at Upcoming Scientific Conferences
December 06, 2022 08:00 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Dec. 06, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
HTG Molecular Diagnostics Reports Third Quarter 2022 Results
November 10, 2022 16:05 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Nov. 10, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
HTG to Collaborate With OmiCure, Providing Transcriptomic Data Across Several Cancer Indications
October 26, 2022 08:00 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz. and PARIS, Oct. 26, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative...
HTG Provides Update on Third Quarter Progress Toward Its Transcriptome-Informed Approach to Drug Discovery
October 12, 2022 16:05 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Oct. 12, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
HTG Molecular Diagnostics to Participate in the Cantor Fitzgerald Oncology, Hematology & HemeOnc Conference
September 26, 2022 08:00 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Sept. 26, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
The Fundación Instituto Valenciano de Oncología Leverages HTG Technology for Breast Cancer Laboratory-Developed Test
September 20, 2022 16:05 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Sept. 20, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
HTG Molecular Diagnostics Reports Second Quarter 2022 Results
August 11, 2022 16:05 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Aug. 11, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...